Acute Administration of Fish Oil Inhibits Triggered Activity in Isolated Myocytes From Rabbits and Patients With Heart Failure
Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on disturbed calcium handling. We hypothesized that superfusion with omega3-polyunsaturated fatty acids (omega3-PUFAs) from fish inhibits triggered activit...
Saved in:
Published in | Circulation (New York, N.Y.) Vol. 117; no. 4; pp. 536 - 544 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
29.01.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on disturbed calcium handling. We hypothesized that superfusion with omega3-polyunsaturated fatty acids (omega3-PUFAs) from fish inhibits triggered activity in heart failure.
Ventricular myocytes were isolated from explanted hearts of rabbits with volume- and pressure-overload-induced heart failure and of patients with end-stage heart failure. Membrane potentials (patch-clamp technique) and intracellular calcium (indo-1 fluorescence) were recorded after 5 minutes of superfusion with Tyrode's solution (control), omega-9 monounsaturated fatty acid oleic acid (20 micromol/L), or omega3-PUFAs (docosahexaenoic acid or eicosapentaenoic acid 20 micromol/L). omega3-PUFAs shortened the action potential at low stimulation frequencies and caused an approximately 25% decrease in diastolic and systolic calcium (all P<0.05). Subsequently, noradrenalin and rapid pacing were used to evoke triggered activity, delayed afterdepolarizations, and calcium aftertransients. omega3-PUFAs abolished triggered activity and reduced the number of delayed afterdepolarizations and calcium aftertransients compared with control and oleic acid. Omega3-PUFAs reduced action potential shortening and intracellular calcium elevation in response to noradrenalin. Results from human myocytes were in accordance with the findings obtained in rabbit myocytes.
Superfusion with omega3-PUFAs from fish inhibits triggered arrhythmias in myocytes from rabbits and patients with heart failure by lowering intracellular calcium and reducing the response to noradrenalin. |
---|---|
AbstractList | BACKGROUNDFish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on disturbed calcium handling. We hypothesized that superfusion with omega3-polyunsaturated fatty acids (omega3-PUFAs) from fish inhibits triggered activity in heart failure.METHODS AND RESULTSVentricular myocytes were isolated from explanted hearts of rabbits with volume- and pressure-overload-induced heart failure and of patients with end-stage heart failure. Membrane potentials (patch-clamp technique) and intracellular calcium (indo-1 fluorescence) were recorded after 5 minutes of superfusion with Tyrode's solution (control), omega-9 monounsaturated fatty acid oleic acid (20 micromol/L), or omega3-PUFAs (docosahexaenoic acid or eicosapentaenoic acid 20 micromol/L). omega3-PUFAs shortened the action potential at low stimulation frequencies and caused an approximately 25% decrease in diastolic and systolic calcium (all P<0.05). Subsequently, noradrenalin and rapid pacing were used to evoke triggered activity, delayed afterdepolarizations, and calcium aftertransients. omega3-PUFAs abolished triggered activity and reduced the number of delayed afterdepolarizations and calcium aftertransients compared with control and oleic acid. Omega3-PUFAs reduced action potential shortening and intracellular calcium elevation in response to noradrenalin. Results from human myocytes were in accordance with the findings obtained in rabbit myocytes.CONCLUSIONSSuperfusion with omega3-PUFAs from fish inhibits triggered arrhythmias in myocytes from rabbits and patients with heart failure by lowering intracellular calcium and reducing the response to noradrenalin. Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on disturbed calcium handling. We hypothesized that superfusion with omega3-polyunsaturated fatty acids (omega3-PUFAs) from fish inhibits triggered activity in heart failure. Ventricular myocytes were isolated from explanted hearts of rabbits with volume- and pressure-overload-induced heart failure and of patients with end-stage heart failure. Membrane potentials (patch-clamp technique) and intracellular calcium (indo-1 fluorescence) were recorded after 5 minutes of superfusion with Tyrode's solution (control), omega-9 monounsaturated fatty acid oleic acid (20 micromol/L), or omega3-PUFAs (docosahexaenoic acid or eicosapentaenoic acid 20 micromol/L). omega3-PUFAs shortened the action potential at low stimulation frequencies and caused an approximately 25% decrease in diastolic and systolic calcium (all P<0.05). Subsequently, noradrenalin and rapid pacing were used to evoke triggered activity, delayed afterdepolarizations, and calcium aftertransients. omega3-PUFAs abolished triggered activity and reduced the number of delayed afterdepolarizations and calcium aftertransients compared with control and oleic acid. Omega3-PUFAs reduced action potential shortening and intracellular calcium elevation in response to noradrenalin. Results from human myocytes were in accordance with the findings obtained in rabbit myocytes. Superfusion with omega3-PUFAs from fish inhibits triggered arrhythmias in myocytes from rabbits and patients with heart failure by lowering intracellular calcium and reducing the response to noradrenalin. Background— Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on disturbed calcium handling. We hypothesized that superfusion with ω3-polyunsaturated fatty acids (ω3-PUFAs) from fish inhibits triggered activity in heart failure. Methods and Results— Ventricular myocytes were isolated from explanted hearts of rabbits with volume- and pressure-overload–induced heart failure and of patients with end-stage heart failure. Membrane potentials (patch-clamp technique) and intracellular calcium (indo-1 fluorescence) were recorded after 5 minutes of superfusion with Tyrode’s solution (control), ω-9 monounsaturated fatty acid oleic acid (20 μmol/L), or ω3-PUFAs (docosahexaenoic acid or eicosapentaenoic acid 20 μmol/L). ω3-PUFAs shortened the action potential at low stimulation frequencies and caused an ≈25% decrease in diastolic and systolic calcium (all P <0.05). Subsequently, noradrenalin and rapid pacing were used to evoke triggered activity, delayed afterdepolarizations, and calcium aftertransients. ω3-PUFAs abolished triggered activity and reduced the number of delayed afterdepolarizations and calcium aftertransients compared with control and oleic acid. ω3-PUFAs reduced action potential shortening and intracellular calcium elevation in response to noradrenalin. Results from human myocytes were in accordance with the findings obtained in rabbit myocytes. Conclusion— Superfusion with ω3-PUFAs from fish inhibits triggered arrhythmias in myocytes from rabbits and patients with heart failure by lowering intracellular calcium and reducing the response to noradrenalin. BACKGROUND: Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on disturbed calcium handling. We hypothesized that superfusion with omega 3-polyunsaturated fatty acids ( omega 3-PUFAs) from fish inhibits triggered activity in heart failure. METHOD:S: and Results- Ventricular myocytes were isolated from explanted hearts of rabbits with volume- and pressure-overload-induced heart failure and of patients with end-stage heart failure. Membrane potentials (patch-clamp technique) and intracellular calcium (indo-1 fluorescence) were recorded after 5 minutes of superfusion with Tyrode's solution (control), omega -9 monounsaturated fatty acid oleic acid (20 mu mol/L), or omega 3-PUFAs (docosahexaenoic acid or eicosapentaenoic acid 20 mu mol/L). omega 3-PUFAs shortened the action potential at low stimulation frequencies and caused an approximately 25% decrease in diastolic and systolic calcium (all P<0.05). Subsequently, noradrenalin and rapid pacing were used to evoke triggered activity, delayed afterdepolarizations, and calcium aftertransients. omega 3-PUFAs abolished triggered activity and reduced the number of delayed afterdepolarizations and calcium aftertransients compared with control and oleic acid. omega 3-PUFAs reduced action potential shortening and intracellular calcium elevation in response to noradrenalin. Results from human myocytes were in accordance with the findings obtained in rabbit myocytes. CONCLUSION: Superfusion with omega 3-PUFAs from fish inhibits triggered arrhythmias in myocytes from rabbits and patients with heart failure by lowering intracellular calcium and reducing the response to noradrenalin. |
Author | CORONEL, Ruben BERECKI, Géza VERKERK, Arie O BELTERMAN, Charly N. W DEN RUIJTER, Hester M BAKKER, Diane BAARTSCHEER, Antonius DE JONGE, Nicolaas SCHUMACHER, Cees A BROUWER, Ingeborg A FIOLET, Jan W. T |
Author_xml | – sequence: 1 givenname: Hester M surname: DEN RUIJTER fullname: DEN RUIJTER, Hester M organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 2 givenname: Géza surname: BERECKI fullname: BERECKI, Géza organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 3 givenname: Ruben surname: CORONEL fullname: CORONEL, Ruben organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 4 givenname: Arie O surname: VERKERK fullname: VERKERK, Arie O organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 5 givenname: Diane surname: BAKKER fullname: BAKKER, Diane organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 6 givenname: Antonius surname: BAARTSCHEER fullname: BAARTSCHEER, Antonius organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 7 givenname: Cees A surname: SCHUMACHER fullname: SCHUMACHER, Cees A organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 8 givenname: Charly N. W surname: BELTERMAN fullname: BELTERMAN, Charly N. W organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 9 givenname: Nicolaas surname: DE JONGE fullname: DE JONGE, Nicolaas organization: Department of Cardiology Heart Lung Center, University Medical Center Utrecht, Utrecht, Netherlands – sequence: 10 givenname: Jan W. T surname: FIOLET fullname: FIOLET, Jan W. T organization: Department of Experimental Cardiology, Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands – sequence: 11 givenname: Ingeborg A surname: BROUWER fullname: BROUWER, Ingeborg A organization: Top Institute Food and Nutrition, Wageningen, Netherlands |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20040952$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18195172$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9v1DAUxC1URLctXwGZA9yy-E8cJ8do1WUjLd2q2opj5DjPXaPELraDtBc-O4FdgTj19DSj38w7zBW6cN4BQu8pWVJa0E-r5mH1uK33ze6u3tRLSuRScs5Z9QotqGB5lgteXaAFIaTKJGfsEl3F-G2WBZfiDbqkJa0ElWyBftZ6SoDrfrTOxhRUst5hb_DaxgPe2QE37mA7myLeB_v0BAF6XOtkf9h0xNbhJvpBpdn8cvT6mCDidfAjflDdn5ByPb6fS8HN4qtNB7wBFRJeKztMAW7Qa6OGCG_P9xo9rm_3q0223X1uVvU203lRpqwznJq-kLk0RlAjizI32gheFMQQraHsjBJS51AwXRoOvSLAhZZ9oSiTUvJr9PHU-xz89wliakcbNQyDcuCn2ErCcsIr_iLIiKg4oWIGqxOog48xgGmfgx1VOLaUtL9Xav9fabZle1ppzr47P5m6Efp_yfMsM_DhDKio1WCCctrGvxwjJCeVYPwXdzyftQ |
CODEN | CIRCAZ |
CitedBy_id | crossref_primary_10_1007_s12012_009_9051_5 crossref_primary_10_1186_1476_511X_9_39 crossref_primary_10_1016_j_nutres_2009_09_011 crossref_primary_10_1016_S0140_6736_10_60445_X crossref_primary_10_1016_j_pharmthera_2013_05_011 crossref_primary_10_1016_j_biopha_2021_111527 crossref_primary_10_1111_j_1748_5827_2010_00968_x crossref_primary_10_1007_s10557_009_6172_9 crossref_primary_10_1007_s10557_009_6174_7 crossref_primary_10_1016_j_pharmthera_2017_02_004 crossref_primary_10_1016_j_hrthm_2011_04_018 crossref_primary_10_3390_nu2030375 crossref_primary_10_1093_eurheartj_ehp111 crossref_primary_10_1139_cjpp_2013_0077 crossref_primary_10_1111_j_1476_5381_2009_00189_x crossref_primary_10_1016_j_jacc_2010_11_072 crossref_primary_10_1016_j_mam_2018_03_003 crossref_primary_10_3945_jn_111_149633 crossref_primary_10_1007_s12265_010_9243_1 crossref_primary_10_1007_s00210_014_0975_3 crossref_primary_10_1016_j_transproceed_2011_01_164 crossref_primary_10_1016_j_ijcard_2014_08_055 crossref_primary_10_1016_j_freeradbiomed_2015_04_014 crossref_primary_10_1016_j_hrthm_2009_10_007 crossref_primary_10_1161_JAHA_121_026756 crossref_primary_10_1080_00325481_2020_1783937 crossref_primary_10_1016_j_bbadis_2013_04_002 crossref_primary_10_1016_j_jcdr_2013_02_013 crossref_primary_10_1007_s11745_010_3503_3 crossref_primary_10_1371_journal_pone_0078414 crossref_primary_10_1007_s12576_017_0544_x crossref_primary_10_1016_j_biopha_2024_116355 crossref_primary_10_3390_ijms23031416 crossref_primary_10_1007_BF03297630 crossref_primary_10_1007_s13105_019_00670_y crossref_primary_10_1038_ejcn_2010_50 crossref_primary_10_1007_s10974_016_9459_z crossref_primary_10_1536_ihj_16_278 crossref_primary_10_1016_j_jada_2008_12_022 crossref_primary_10_1016_j_pharmthera_2011_02_002 crossref_primary_10_1152_ajpheart_01065_2009 crossref_primary_10_1002_ejlt_201400212 crossref_primary_10_1007_s11883_009_0066_y crossref_primary_10_3389_fphys_2023_1326160 crossref_primary_10_1080_14779072_2022_2103541 crossref_primary_10_1016_j_lfs_2011_05_013 crossref_primary_10_1016_S1674_8301_11_60037_7 |
Cites_doi | 10.1016/S0140-6736(89)90828-3 10.1001/jama.295.22.2613 10.1016/S0014-2999(98)00528-7 10.1038/sj.ejcn.1601539 10.1073/pnas.92.9.3997 10.1016/S0008-6363(03)00460-7 10.1016/j.cardiores.2006.02.022 10.1001/jama.293.23.2884 10.1016/j.ejheart.2004.03.001 10.1093/cvr/28.10.1547 10.1016/S0008-6363(02)00854-4 10.1016/S0008-6363(03)00545-5 10.1113/jphysiol.1976.sp011622 10.1016/j.bbrc.2004.06.114 10.1016/S0140-6736(99)07072-5 10.1161/01.CIR.92.12.3497 10.1016/S0008-6363(00)00064-X 10.1093/jn/134.12.3250 10.1053/euhj.2000.2499 10.1006/jmcc.2000.1145 10.1161/circ.92.4.1034 10.1113/jphysiol.2001.013015 10.1161/circ.98.22.2404 10.1016/j.cardiores.2003.11.018 10.1016/S0955-2863(01)00151-6 10.1073/pnas.94.8.4182 10.1007/s00232-003-0628-9 10.1111/j.1469-7793.2000.t01-1-00367.x 10.1093/clinchem/39.5.825 10.1161/circ.104.22.2728 10.1073/pnas.92.24.11000 |
ContentType | Journal Article |
Copyright | 2008 INIST-CNRS |
Copyright_xml | – notice: 2008 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7X8 |
DOI | 10.1161/CIRCULATIONAHA.107.733329 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef Calcium & Calcified Tissue Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1524-4539 |
EndPage | 544 |
ExternalDocumentID | 10_1161_CIRCULATIONAHA_107_733329 18195172 20040952 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 08R 0R~ 0ZK 18M 1CY 1J1 29B 2FS 2WC 354 40H 41~ 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAXR AAEJM AAGIX AAHPQ AAJCS AAMOA AAMTA AAPBV AAQKA AARTV AASOK AASXQ AAUGY AAWTL AAXQO AAYOK ABASU ABBUW ABDIG ABOCM ABPMR ABPTK ABQRW ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACOAL ACRKK ACRZS ACWDW ACWRI ACXNZ ADBBV ADCYY ADFPA ADGGA ADNKB AE3 AE6 AEBDS AEETU AENEX AFCHL AFDTB AFFNX AFUWQ AGINI AHMBA AHOMT AHRYX AHVBC AIJEX AJIOK AJJEV AJNWD AJNYG AKALU AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW ASPBG AVWKF AWKKM AYCSE AZFZN BAWUL BOYCO BQLVK BS7 BYPQX C1A C45 CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EEVPB EJD EX3 F2K F2L F2M F2N F5P FCALG FEDTE FL- FW0 GNXGY GQDEL GX1 H0~ H13 HZ~ H~9 IKREB IKYAY IN~ IPNFZ IQODW J5H JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B M18 MVM N4W N9A NEJ N~7 N~B N~M O9- OAG OAH OBH OCB OCUKA ODA ODMTH OGEVE OHH OHT OHYEH OJAPA OK1 OL1 OLB OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RHF RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WHG WOQ WOW X3V X3W X7M XXN XYM YFH YOC YQJ YSK YXB YYM YYP YZZ ZA5 ZFV ZGI ZXP ZY1 ZZMQN ~H1 AAAAV AAIQE AAUEB ABJNI ADHPY AFEXH AHQNM AINUH AJZMW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7X8 |
ID | FETCH-LOGICAL-c468t-bf31fd6747ff51f7684fcf53660f0cce8bfa57c4e62c8f3eda0e35c7d6a127773 |
ISSN | 0009-7322 |
IngestDate | Fri Oct 25 07:28:34 EDT 2024 Fri Oct 25 01:21:21 EDT 2024 Fri Aug 23 02:32:58 EDT 2024 Tue Oct 15 23:31:14 EDT 2024 Sun Oct 22 16:03:59 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Heart failure Calcium Arrhythmia fatty acids Electrophysiology Rabbit Cardiovascular disease Lagomorpha Inorganic element Fish oil Myocyte Vertebrata Mammalia Heart disease Animal |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c468t-bf31fd6747ff51f7684fcf53660f0cce8bfa57c4e62c8f3eda0e35c7d6a127773 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://doi.org/10.1161/circulationaha.107.733329 |
PMID | 18195172 |
PQID | 20593015 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_70240393 proquest_miscellaneous_20593015 crossref_primary_10_1161_CIRCULATIONAHA_107_733329 pubmed_primary_18195172 pascalfrancis_primary_20040952 |
PublicationCentury | 2000 |
PublicationDate | 2008-01-29 |
PublicationDateYYYYMMDD | 2008-01-29 |
PublicationDate_xml | – month: 01 year: 2008 text: 2008-01-29 day: 29 |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Circulation (New York, N.Y.) |
PublicationTitleAlternate | Circulation |
PublicationYear | 2008 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | 18625900 - Circulation. 2008 Jul 15;118(3):e69; author reply e70 e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 (e_1_3_2_14_2) 1991; 261 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 |
References_xml | – ident: e_1_3_2_1_2 doi: 10.1016/S0140-6736(89)90828-3 – ident: e_1_3_2_17_2 doi: 10.1001/jama.295.22.2613 – ident: e_1_3_2_8_2 doi: 10.1016/S0014-2999(98)00528-7 – ident: e_1_3_2_21_2 doi: 10.1038/sj.ejcn.1601539 – ident: e_1_3_2_32_2 doi: 10.1073/pnas.92.9.3997 – ident: e_1_3_2_16_2 doi: 10.1016/S0008-6363(03)00460-7 – ident: e_1_3_2_27_2 doi: 10.1016/j.cardiores.2006.02.022 – ident: e_1_3_2_22_2 doi: 10.1001/jama.293.23.2884 – ident: e_1_3_2_34_2 doi: 10.1016/j.ejheart.2004.03.001 – ident: e_1_3_2_6_2 doi: 10.1093/cvr/28.10.1547 – ident: e_1_3_2_5_2 doi: 10.1016/S0008-6363(02)00854-4 – ident: e_1_3_2_29_2 doi: 10.1016/S0008-6363(03)00545-5 – ident: e_1_3_2_7_2 doi: 10.1113/jphysiol.1976.sp011622 – ident: e_1_3_2_28_2 doi: 10.1016/j.bbrc.2004.06.114 – ident: e_1_3_2_4_2 – ident: e_1_3_2_2_2 doi: 10.1016/S0140-6736(99)07072-5 – ident: e_1_3_2_15_2 doi: 10.1161/01.CIR.92.12.3497 – ident: e_1_3_2_11_2 doi: 10.1016/S0008-6363(00)00064-X – ident: e_1_3_2_31_2 doi: 10.1093/jn/134.12.3250 – ident: e_1_3_2_19_2 doi: 10.1053/euhj.2000.2499 – volume: 261 start-page: H301 year: 1991 ident: e_1_3_2_14_2 publication-title: Am J Physiol – ident: e_1_3_2_20_2 doi: 10.1006/jmcc.2000.1145 – ident: e_1_3_2_23_2 doi: 10.1161/circ.92.4.1034 – ident: e_1_3_2_12_2 doi: 10.1113/jphysiol.2001.013015 – ident: e_1_3_2_33_2 doi: 10.1161/circ.98.22.2404 – ident: e_1_3_2_3_2 doi: 10.1016/j.cardiores.2003.11.018 – ident: e_1_3_2_26_2 doi: 10.1016/S0955-2863(01)00151-6 – ident: e_1_3_2_24_2 – ident: e_1_3_2_10_2 doi: 10.1073/pnas.94.8.4182 – ident: e_1_3_2_30_2 doi: 10.1007/s00232-003-0628-9 – ident: e_1_3_2_13_2 doi: 10.1111/j.1469-7793.2000.t01-1-00367.x – ident: e_1_3_2_18_2 doi: 10.1093/clinchem/39.5.825 – ident: e_1_3_2_25_2 doi: 10.1161/circ.104.22.2728 – ident: e_1_3_2_9_2 doi: 10.1073/pnas.92.24.11000 |
SSID | ssj0006375 |
Score | 2.2479472 |
Snippet | Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on disturbed... Background— Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on... BACKGROUND: Fish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on... BACKGROUNDFish oil reduces sudden death in patients with prior myocardial infarction. Sudden death in heart failure may be due to triggered activity based on... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 536 |
SubjectTerms | Action Potentials Animals Arrhythmias, Cardiac - prevention & control Biological and medical sciences Blood and lymphatic vessels Calcium - analysis Cardiology. Vascular system Cells, Cultured Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Fatty Acids, Omega-3 - pharmacology Fatty Acids, Unsaturated - pharmacology Fish Oils - pharmacology Fundamental and applied biological sciences. Psychology General aspects Heart Failure - pathology Humans Medical sciences Membrane Potentials Muscle Cells - cytology Muscle Cells - drug effects Norepinephrine - pharmacology Rabbits Vertebrates: cardiovascular system |
Title | Acute Administration of Fish Oil Inhibits Triggered Activity in Isolated Myocytes From Rabbits and Patients With Heart Failure |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18195172 https://search.proquest.com/docview/20593015 https://search.proquest.com/docview/70240393 |
Volume | 117 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9pAEF_kCkehlPau7dmP6xZKXyTWZPOhj9Yqep4KouXeZLPZ7QWu8fDig_fQf7f_Rmd2k2hapR8gQZaNSZxfZmd2Zn5DyHvbaYSRlL7lw9oHDordtDh3sGI5Ajg1VMttYHHyaOz35-7FlXdVqfzYyVpap2Fd3O-tK_kfqcIYyBWrZP9BssWPwgB8B_nCESQMx7-ScVtglL_Mf4vWH_Yzr01iZNG4jkMMDczACf-KbTlrbZH1i4iT2gBuj6PJOdosxQZ3YHtYbTLloT5JFxIY3lVMk02vsWhpldZ6PL7JiEgKkoN4JbJGYPv6--zsN3zujmvT-eBiZlIw-pqpYbsn-6k77XaGA71db4L499tcosl0Mu5ealSsw20N25fudAgfrebA869NSlsZmEVnOVuFuY-SQm9lxDeYL1RS4y0rYKaguS4zze24lusZZqRCtZu60AzD7o6i9pi_s-Z7hoPy9-XEx-WkM5h25peGnLjfroPDXA8YY9mdlyi8f1lai4RHRC0Ys2ArPHBAI-p8gsGwMBl8Fnh5yz98rmPyLrv8x4MXLxlSj275HbzTyjRjOewtaatp9oQ8ztwd2jbYfUoqMjkhp-2Ep8tvG_qB6gRkHdk5IcejLM_jlHzXyKZlZNOloohsCsimObJpgWyaI5vGCc2RTXNkU0Q2zZBNAdk0RzZFZFONbJoh-xmZ97qzTt_KOoVYwvWbqRUqZqvIB9dYKc9WGFxWQoGM_YZqCCGboeJeIFzpO6KpmIx4QzJPBJHPbScIAvacHCXLRJ4R2hQOYzDM7WboRrLFI69lw3wX_HCYKKvEyf_2xa0hhFloR9q3F2VZwXCwMLKqkvOSgIozc1xUydtcYgvQ7xi044lcru9ghtcCrekdnhEgTSFrsSp5YUS9vS8MkoOH8vJPl39FHm7fx9fkKF2t5RswttPwXAP1Jzpk0C4 |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+Administration+of+Fish+Oil+Inhibits+Triggered+Activity+in+Isolated+Myocytes+From+Rabbits+and+Patients+With+Heart+Failure&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=DEN+RUIJTER%2C+Hester+M&rft.au=BERECKI%2C+G%C3%A9za&rft.au=CORONEL%2C+Ruben&rft.au=VERKERK%2C+Arie+O&rft.date=2008-01-29&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=117&rft.issue=4&rft.spage=536&rft.epage=544&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.107.733329&rft.externalDBID=n%2Fa&rft.externalDocID=20040952 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |